These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25569270)

  • 1. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.
    Hendy LE; Spees LP; Tak C; Carpenter DM; Thomas KC; Roberts MC
    Atherosclerosis; 2024 Jun; 393():117541. PubMed ID: 38677159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands.
    Ademi Z; Norman R; Pang J; Sijbrands E; Watts GF; Hutten BA; Wiegman A
    JAMA Pediatr; 2023 Jun; 177(6):625-632. PubMed ID: 37126315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review.
    Marquina C; Morton JI; Lloyd M; Abushanab D; Baek Y; Abebe T; Livori A; Dahal P; Watts GF; Ademi Z
    Pharmacoeconomics; 2024 Apr; 42(4):373-392. PubMed ID: 38265575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia.
    Meng R; Wei Q; Zhou J; Zhang B; Li C; Shen M
    J Clin Lipidol; 2024; 18(1):e21-e32. PubMed ID: 37980172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the question.
    Marquina C; Morton JI; Ademi Z
    Curr Opin Endocrinol Diabetes Obes; 2024 Apr; 31(2):84-89. PubMed ID: 37983310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon.
    O'Brien TD; Potter AB; Driscoll CC; Goh G; Letaw JH; McCabe S; Thanner J; Kulkarni A; Wong R; Medica S; Week T; Buitrago J; Larson A; Camacho KJ; Brown K; Crist R; Conrad C; Evans-Dutson S; Lutz R; Mitchell A; Anur P; Serrato V; Shafer A; Marriott LK; Hamman KJ; Mulford A; Wiszniewski W; Sampson JE; Adey A; O'Roak BJ; Harrington CA; Shannon J; Spellman PT; Richards CS
    Am J Hum Genet; 2023 Aug; 110(8):1249-1265. PubMed ID: 37506692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
    Singh S; Bittner V
    Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
    Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
    Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of familial hypercholesterolemia and emerging therapies.
    Vogt A
    Appl Clin Genet; 2015; 8():27-36. PubMed ID: 25670911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of genetic screening for Lynch syndrome in Germany.
    Severin F; Stollenwerk B; Holinski-Feder E; Meyer E; Heinemann V; Giessen-Jung C; Rogowski W
    Genet Med; 2015 Oct; 17(10):765-73. PubMed ID: 25569434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction.
    Wald DS; Bangash FA; Bestwick JP
    Eur J Intern Med; 2015 Mar; 26(2):127-30. PubMed ID: 25682442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.
    Braamskamp MJ; Kusters DM; Avis HJ; Smets EM; Wijburg FA; Kastelein JJ; Wiegman A; Hutten BA
    Paediatr Drugs; 2015 Apr; 17(2):159-66. PubMed ID: 25644328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia.
    Benito-Vicente A; Alves AC; Etxebarria A; Medeiros AM; Martin C; Bourbon M
    Genet Med; 2015 Dec; 17(12):980-8. PubMed ID: 25741862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of familial hypercholesterolemia.
    Brautbar A; Leary E; Rasmussen K; Wilson DP; Steiner RD; Virani S
    Curr Atheroscler Rep; 2015 Apr; 17(4):491. PubMed ID: 25712136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Would raising the total cholesterol diagnostic cut-off from 7.5 mmol/L to 9.3 mmol/L improve detection rate of patients with monogenic familial hypercholesterolaemia?
    Futema M; Kumari M; Boustred C; Kivimaki M; Humphries SE
    Atherosclerosis; 2015 Apr; 239(2):295-8. PubMed ID: 25682026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study.
    Pang J; Sullivan DR; Harada-Shiba M; Ding PY; Selvey S; Ali S; Watts GF
    J Clin Lipidol; 2015; 9(1):42-8. PubMed ID: 25670359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.
    Vassy JL; Christensen KD; Slashinski MJ; Lautenbach DM; Raghavan S; Robinson JO; Blumenthal-Barby J; Feuerman LZ; Lehmann LS; Murray MF; Green RC; McGuire AL
    Per Med; 2015; 12(1):23-32. PubMed ID: 25642274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.
    Santos RD; Raal FJ; Catapano AL; Witztum JL; Steinhagen-Thiessen E; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):689-99. PubMed ID: 25614280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.